Green Cross Medical Science Corporation Capital Reinvestment Ratio
Green Cross Medical Science Corporation capital reinvestment ratio. Green Cross Medical Science Corporation (142280) has a Capital Reinvestment Ratio of 0.09x as of December 2025, meaning it reinvests 0% of its operating cash flow (₩5.01 Billion) in capital expenditures (₩460.89 Million). Check cash flow reinvestment rate of Green Cross Medical Science Corporation to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Green Cross Medical Science Corporation (2016–2025)
Capital reinvestment ratio of Green Cross Medical Science Corporation from 2016 to 2025. This chart tracks Green Cross Medical Science Corporation's Capital Reinvestment Ratio across 6 annual periods. Also explore Green Cross Medical Science Corporation net asset momentum to track the company's year-over-year net asset growth rate.
Green Cross Medical Science Corporation Capital Reinvestment Ratio by Year (2016–2025)
Green Cross Medical Science Corporation capital reinvestment ratio by year from 2016 to 2025. For the full cash flow conversion analysis, see 142280 cash flow metrics.
| Year | Reinvestment Ratio | Operating CF (KRW) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.68x | ₩7.20 Billion | ₩4.90 Billion | ▼ -22.5% |
| 2024 | 0.88x | ₩3.66 Billion | ₩3.22 Billion | ▼ -33.9% |
| 2023 | 1.33x | ₩4.24 Billion | ₩5.63 Billion | ▲ +321.7% |
| 2022 | 0.31x | ₩10.88 Billion | ₩3.43 Billion | ▼ -11.4% |
| 2017 | 0.36x | ₩3.11 Billion | ₩1.11 Billion | ▲ +93.2% |
| 2016 | 0.18x | ₩10.25 Billion | ₩1.89 Billion | — |